http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1097207-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_118c67f26896cd001e6ee42e548349dc
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 1965-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1967-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1097207-A
titleOfInvention Process for the preparation of sustained action tablets
abstract Sustained-release pharmaceutical tablets are prepared by forming an emulsion of a molten mixture of mono- and di-saccharides containing 1-4% water in a molten, non-toxic, thermoplastic substance which is substantially insoluble in gastric or intestinal juices, e.g. a natural or synthetic elastomer such as natural rubber, chicle gum, cis- or trans-polybutadiene or polyisobutylene, cooling the mass and forming it into tablets after addition of therapeutically active ingredients. The active ingredients may be added to the sugar mixture before emulsification or, the emulsified mass may be cooled, subdivided and mixed with the active material, the mixture being formed into tablets which are subsequently sintered by heating.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10493026-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5478574-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8968769-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8313768-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9789066-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9511028-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8871263-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011038070-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8343533-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9610224-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5670168-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9233491-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8807979-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2178658-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8858210-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8784781-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9445971-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8865204-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5169639-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9107807-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5472711-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5135757-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4994276-A
priorityDate 1964-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 38.